CALR and neoplasm: NcRNA-RB1 (a lncRNA expressed in the RB1 promoter) suppresses the expression of calreticulin, which is a calcium-binding chaperone and affects the presentation of antigen to cytotoxic T cells, and prevents tumor cells release “killing me” signal [20].